214 related articles for article (PubMed ID: 29903916)
21. Type 1 Insulin-Like Growth Factor Receptor/Insulin Receptor Substrate 1 Signaling Confers Pathogenic Activity on Breast Tumor Cells Lacking REST.
Meyer K; Albaugh B; Schoenike B; Roopra A
Mol Cell Biol; 2015 Sep; 35(17):2991-3004. PubMed ID: 26100015
[TBL] [Abstract][Full Text] [Related]
22. Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity.
Tognon CE; Mackereth CD; Somasiri AM; McIntosh LP; Sorensen PH
Mol Cell Biol; 2004 Jun; 24(11):4636-50. PubMed ID: 15143160
[TBL] [Abstract][Full Text] [Related]
23. Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation.
Saisana M; Griffin SM; May FE
Oncotarget; 2016 Aug; 7(34):54445-54462. PubMed ID: 27437872
[TBL] [Abstract][Full Text] [Related]
24. Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605.
Pappano WN; Jung PM; Meulbroek JA; Wang YC; Hubbard RD; Zhang Q; Grudzien MM; Soni NB; Johnson EF; Sheppard GS; Donawho C; Buchanan FG; Davidsen SK; Bell RL; Wang J
BMC Cancer; 2009 Sep; 9():314. PubMed ID: 19732452
[TBL] [Abstract][Full Text] [Related]
25. TGFβ and IGF1R signaling activates protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells.
Leiphrakpam PD; Brattain MG; Black JD; Wang J
J Biol Chem; 2018 May; 293(21):8242-8254. PubMed ID: 29599290
[TBL] [Abstract][Full Text] [Related]
26. Targeting the E3 ligase NEDD4 as a novel therapeutic strategy for IGF1 signal pathway-driven gastric cancer.
Wang K; Yu Y; Wang W; Jiang Y; Li Y; Jiang X; Qiao Y; Chen L; Zhao X; Liu J; Yang A; Li J; Zhang R
Oncogene; 2023 Mar; 42(14):1072-1087. PubMed ID: 36774408
[TBL] [Abstract][Full Text] [Related]
27. Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage.
Waraky A; Lin Y; Warsito D; Haglund F; Aleem E; Larsson O
J Biol Chem; 2017 Nov; 292(44):18227-18239. PubMed ID: 28924044
[TBL] [Abstract][Full Text] [Related]
28. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH
Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor-1 signaling in renal cell carcinoma.
Tracz AF; Szczylik C; Porta C; Czarnecka AM
BMC Cancer; 2016 Jul; 16():453. PubMed ID: 27405474
[TBL] [Abstract][Full Text] [Related]
30. The ETV6-NTRK3 chimeric tyrosine kinase suppresses TGF-beta signaling by inactivating the TGF-beta type II receptor.
Jin W; Kim BC; Tognon C; Lee HJ; Patel S; Lannon CL; Maris JM; Triche TJ; Sorensen PH; Kim SJ
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16239-44. PubMed ID: 16258068
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of G Protein-Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth.
Crudden C; Shibano T; Song D; Dragomir MP; Cismas S; Serly J; Nedelcu D; Fuentes-Mattei E; Tica A; Calin GA; Girnita A; Girnita L
Cancer Res; 2021 Jan; 81(2):501-514. PubMed ID: 33158816
[TBL] [Abstract][Full Text] [Related]
32. Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells.
Chan JY; LaPara K; Yee D
Oncogene; 2016 Aug; 35(32):4235-43. PubMed ID: 26876199
[TBL] [Abstract][Full Text] [Related]
33. Loss of E-cadherin Enhances IGF1-IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors.
Nagle AM; Levine KM; Tasdemir N; Scott JA; Burlbaugh K; Kehm J; Katz TA; Boone DN; Jacobsen BM; Atkinson JM; Oesterreich S; Lee AV
Clin Cancer Res; 2018 Oct; 24(20):5165-5177. PubMed ID: 29941485
[No Abstract] [Full Text] [Related]
34. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
Iida M; Tsuboi K; Niwa T; Ishida T; Hayashi SI
Breast Cancer; 2019 May; 26(3):272-281. PubMed ID: 30328006
[TBL] [Abstract][Full Text] [Related]
35. Bidirectional signaling between TM4SF5 and IGF1R promotes resistance to EGFR kinase inhibitors.
Choi J; Kang M; Nam SH; Lee GH; Kim HJ; Ryu J; Cheong JG; Jung JW; Kim TY; Lee HY; Lee JW
Lung Cancer; 2015 Oct; 90(1):22-31. PubMed ID: 26190015
[TBL] [Abstract][Full Text] [Related]
36. Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.
Zhou J; Wang J; Zeng Y; Zhang X; Hu Q; Zheng J; Chen B; Xie B; Zhang WM
Oncotarget; 2015 Dec; 6(42):44332-45. PubMed ID: 26554308
[TBL] [Abstract][Full Text] [Related]
37. Combination therapy approaches to target insulin-like growth factor receptor signaling in breast cancer.
Ochnik AM; Baxter RC
Endocr Relat Cancer; 2016 Nov; 23(11):R513-R536. PubMed ID: 27733416
[TBL] [Abstract][Full Text] [Related]
38. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
[TBL] [Abstract][Full Text] [Related]
39. Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation.
Cetinbas N; Huang-Hobbs H; Tognon C; Leprivier G; An J; McKinney S; Bowden M; Chow C; Gleave M; McIntosh LP; Sorensen PH
J Biol Chem; 2013 Sep; 288(39):27940-50. PubMed ID: 23798677
[TBL] [Abstract][Full Text] [Related]
40. LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation.
Tworkoski K; Raab-Traub N
J Virol; 2015 Mar; 89(5):2590-602. PubMed ID: 25520502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
